ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3190

Epidemiology of Polymyalgia Rheumatica 2000-2014: A Population Based Study

Shafay Raheel1, Cynthia S. Crowson2 and Eric L. Matteson1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: polymyalgia rheumatica

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Epidemiology and Public Health III: Psoriatic Arthritis and More

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: To determine time trends in the incidence and survival analysis of polymyalgia rheumatica (PMR) over a 15 year period in a geographically defined population and to descriptively compare the incidence of PMR in this time period to a previous incidence cohort from the same population base.

Methods: In a geographically defined population, we retrospectively identified all incident cases of PMR between January 1, 2000, and December 31, 2014. Detailed review of all individual medical records was performed. All but 4 of these cases (who were age<50 years) fulfilled EULAR/ACR classification criteria for PMR. Incidence rates were age and sex adjusted to the US white 2010 population and were graphically illustrated using 3 year centered moving averages. Survival rates were computed using Kaplan-Meier methods and were compared with the expected rates in the population of the US State.

Results: There were 407 incident cases of PMR during the 15 year study period. Of these 64% were female and the mean age at incidence was 73.9 years. The overall age and sex adjusted annual incidence of PMR was 68.3 (95% confidence interval [CI] 61.6, 75) per 100,000 population aged ≥50 years. Incidence rates increased with age in both sexes, but incidence fell after age 80 years among women. The incidence rates fluctuated over the period of observation (Figure) with evenly spaced peaks in 1970, 1990 and 2005. Comparing the two time periods, there was a significant increase in incidence of PMR in the recent time period compared to 1970-1999 (age and sex adjusted rate: 55.8 per 100,000; p=0.011). During median follow-up of 6.4 years, 120 patients died. Mortality among individuals with PMR was not significantly worse than that expected in the general population (standardized mortality ratio: 0.73; 95% CI: 0.60, 0.87).

Conclusion: The incidence of PMR has increased slightly in the past 15 years compared to previous decades. Survival among patients with PMR is not worse than the general population. Further research is needed to understand the determinants of the increase in incidence of PMR.

 


Disclosure: S. Raheel, None; C. S. Crowson, None; E. L. Matteson, None.

To cite this abstract in AMA style:

Raheel S, Crowson CS, Matteson EL. Epidemiology of Polymyalgia Rheumatica 2000-2014: A Population Based Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/epidemiology-of-polymyalgia-rheumatica-2000-2014-a-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-of-polymyalgia-rheumatica-2000-2014-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology